InvestorsHub Logo
Followers 17
Posts 10896
Boards Moderated 0
Alias Born 03/11/2017

Re: None

Thursday, 07/20/2017 2:28:31 PM

Thursday, July 20, 2017 2:28:31 PM

Post# of 44784
Can Pluristem Therapeutics Corner The Acute Radiation Syndrome Market?


•Pluristem may deliver the ONLY drug specifically indicated to treat ARS.

•While Amgen and Sanofi have products that can treat symptoms of ARS, they are used off-label.

•BARDA has spent over $150 million to stockpile off-label treatments, opening the door wide open to an approved PSTI indicated treatment.


https://seekingalpha.com/article/4061827-can-pluristem-therapeutics-corner-acute-radiation-syndrome-market